학술논문

Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene
Document Type
article
Source
Retrovirology, Vol 9, Iss Suppl 2, p O50 (2012)
Subject
Immunologic diseases. Allergy
RC581-607
Language
English
ISSN
1742-4690